Cara Benjamin
Overview
Explore the profile of Cara Benjamin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
27
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nath K, Zhang M, Bye M, Abid M, Benjamin C, Betts B, et al.
Blood Adv
. 2025 Mar;
PMID: 40048743
Whether younger donors should be prioritized over HLA-matching for allogeneic hematopoietic cell transplantation (allo-HCT) when using post-transplant cyclophosphamide (PTCy)-based graft versus host disease (GvHD) prophylaxis is unclear. To address this,...
2.
Lin R, Anderson A, Natori Y, Raja M, Morris M, Jimenez A, et al.
Blood Adv
. 2024 Jun;
8(14):3813-3822.
PMID: 38838226
Cytomegalovirus (CMV) reactivation is a major complication among seropositive allogeneic hematopoietic cell transplantation recipients; however, data on CMV reactivation after chimeric antigen receptor (CAR) T-cell therapy are limited. We report...
3.
Cohen J, Shah S, Piedra K, Shalhoub S, Benjamin C, Pereira D
Hematol Transfus Cell Ther
. 2024 Mar;
46 Suppl 5:S37-S42.
PMID: 38485549
High-dose chemotherapy with autologous hematopoietic stem cell transplantation (auto-HSCT) improved 5-year overall survival rates in relapsed/refractory germ cell tumors (GCTs) from 10% to 52%. Nearly 30% of GCT patients are...
4.
Barreras H, Copsel S, Bader C, Ding Y, Wolf D, Cash C, et al.
Transplant Cell Ther
. 2023 Feb;
29(5):341.e1-341.e9.
PMID: 36804930
The present studies examined experimental transplant outcomes using mobilized peripheral blood from mice and humans together with FoxP3+Treg cells. Donor mice were treated with filgrastim and / or plerixafor and...
5.
Camargo J, Kimble E, Rosa R, Shimose L, Bueno M, Jeyakumar N, et al.
Biol Blood Marrow Transplant
. 2017 Dec;
24(4):806-814.
PMID: 29217388
The optimal viral load threshold at which to initiate preemptive cytomegalovirus (CMV) therapy in hematopoietic cell transplantation (HCT) recipients remains to be defined. In an effort to address this question,...
6.
Vence L, Wang C, Pappu H, Anson R, Patel T, Miller P, et al.
J Immunother
. 2013 Apr;
36(4):276-86.
PMID: 23603862
Peptide vaccination against tumor-associated antigens remains one of the most common methods of immunization in cancer vaccine clinical trials. Although peptide vaccination has been reported to increase circulating antigen-specific T-cells,...
7.
Bayraktar U, Kim T, Drews-Elger K, Benjamin C, El-Ashry D, Wieder E, et al.
Breast Cancer Res Treat
. 2011 May;
129(2):623-8.
PMID: 21607585
The activation of human epidermal growth factor receptor-2 (HER2) results in the activation of the mitogen-activated protein kinase (MAPK) cascade that may lead to the resistance to anti-estrogen therapy in...